This site uses cookies for analytics and to improve your experience. By clicking Accept, you consent to our use of cookies. Learn more in our privacy policy.

Skip to content
  • Facebook
  • X
  • YouTube
  • Instagram
  • Pinterest
  • LinkedIn
  • Medium
Subscribe
Life Care News
  • Home
  • Automobile
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • Support Us
  • GlobeNewswire
  • News Voir
  • PR Newswire
  • Pressat
Watch
  • Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
    Tech

    Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

    Globe News Wire
    14/06/2026

    TEL AVIV, Israel, June 14, 2026 (GLOBE NEWSWIRE) — Orbs, the decentralized Layer-3 blockchain infrastructure focused on advanced on-chain trading, today announced Orbs Institutional, a new offering that provides trading desks, OTC firms, treasuries, custodians and financial platforms with direct access to its on-chain execution infrastructure. The launch builds on technology that has processed more…

    Continue Reading

Latest News

View All

  • Tech

    Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

    14/06/2026
    Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
  • Lifestyle, Travel

    Godrej Industries Group Celebrates Pride@Godrej 2026

    14/06/2026
    Godrej Industries Group Celebrates Pride@Godrej 2026
  • Health

    Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

    14/06/2026
  • Food

    Kavalan Hits 1,000 Gold Medal-Milestone: Unveils Most-Awarded Whisky

    14/06/2026
  • Health

    Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

    14/06/2026
    Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

About the Author

Life Care News

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

You May Have Missed

View All

  • Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
    Tech

    Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

    14/06/2026
  • Godrej Industries Group Celebrates Pride@Godrej 2026
    Lifestyle, Travel

    Godrej Industries Group Celebrates Pride@Godrej 2026

    14/06/2026
  • Health

    Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

    14/06/2026
  • Food

    Kavalan Hits 1,000 Gold Medal-Milestone: Unveils Most-Awarded Whisky

    14/06/2026
  • Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
    Health

    Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

    14/06/2026

About the Author

Life Care News

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Latest News

  • Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

    Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
  • Godrej Industries Group Celebrates Pride@Godrej 2026

    Godrej Industries Group Celebrates Pride@Godrej 2026
  • Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

  • Kavalan Hits 1,000 Gold Medal-Milestone: Unveils Most-Awarded Whisky

  • Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

    Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Categories

Automobile Business Entertainment Food Future News Health Lifestyle News Sports Tech Travel

Tags

across announced company global globe india june leading today World

Search

Quick Links

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Home
  • Privacy Policy
  • Support Us
  • Terms & Conditions

Life Care News

  • Home
  • News
  • About Us
  • Contact

Copyright © 2015 – 2026 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283